Skip to main content

Preliminary Trends of the EORTC Study Comparing Postoperative Chemotherapy, Immunotherapy, Chemoimmunotherapy or Abstention in Squamous Cell Bronchial Carcinoma

  • Chapter
Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 68))

  • 66 Accesses

Abstract

This is a very short interim report since, due to the stratification according to nodal status and the first random allocation to groups with and without radiotherapy, there are 16 subgroups among 310 patients available for analysis. For this reason, the EORTC expects no conclusive results before 2 additional years of follow-up. Nevertheless, some trends are beginning to appear that will be summarized below and should be considered as very preliminary.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Reference

  1. Israel, L.: Nonspecific immunostimulation in bronchogenic cancer. Scand. J. Resp. Dis. [Suppl.] 89, 95–105 (1974).

    CAS  Google Scholar 

  2. Israel, L., Edelstein, R., Depierre, A., Dimitrov, N.: Daily intravenous infusions of Corynebacterium parvum in twenty patients with disseminated cancer: A preliminary report of clinical and biologic findings. J.N.C.I. 55, 29–33 (1975).

    CAS  Google Scholar 

  3. Israel, L.: Nonspecific immune stimulation with corynebacteria in lung cancer. In: Lung cancer. Natural history, prognosis, and therapy. Israël, L., Chahinian, P. (eds.), Vol. I, pp. 273-280. New York-London: Academic Press 1976.

    Google Scholar 

  4. Israel, L., Edelstein, R.: In vivo and in vitro studies on nonspecific blocking factors of host origin in cancer patients. Role of plasma exchange as an immunotherapeutic modality. Isr. J. Med. Sci. 14, 105–130 (1978).

    PubMed  CAS  Google Scholar 

  5. Israel, L.: An immunological look at the TNM classification therapeutic implications and strategies. Cancer Treat. Rep. (1978) (in press).

    Google Scholar 

  6. McKneally, M. F., Maver, C., Kansel, H. W.: Regional immunotherapy of lung cancer with intrapleural BCG. Lancet 1976/I, 377-379.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1979 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Israel, L., Depierre, A., Sylvester, R. (1979). Preliminary Trends of the EORTC Study Comparing Postoperative Chemotherapy, Immunotherapy, Chemoimmunotherapy or Abstention in Squamous Cell Bronchial Carcinoma. In: Bonadonna, G., Mathé, G., Salmon, S.E. (eds) Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II. Recent Results in Cancer Research, vol 68. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81332-0_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81332-0_39

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81334-4

  • Online ISBN: 978-3-642-81332-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics